Return to homepagePandemic Pact

Search for new SARS-CoV-2 treatment strategies and viral property analysis starting from anti-HIV drug research

Grant number: 21K08501

Grant search

Key facts

  • Disease

    COVID-19

  • Start & end year

    2021
    2024

  • Known Financial Commitments (USD)

    $37,440

  • Funder

    KAKENHI

  • Principal Investigator

    Keika Harada Unspecified

  • Research Location

    Japan

  • Lead Research Institution

    National Infection Laboratory

  • Research Priority Alignment

    N/A

  • Research Category

    Therapeutics research, development and implementation

  • Research Subcategory

    N/A

  • Special Interest Tags

    N/A

  • Study Type

    Unspecified

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Not Applicable

  • Vulnerable Population

    Not applicable

  • Occupations of Interest

    Not applicable

Abstract

1 Publication linked via Europe PMC

Last Updated:4 days ago

View all publications at Europe PMC

TMPRSS2-induced Golgi disruption restricts the incorporation of virus envelope glycoproteins into virions.